Cargando…
Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19
Autores principales: | Ahmed, O., Mukarram, A.K., Pirazzini, C., Marasco, E. Elena, Pedrelli, M., Minniti, M.E., Gustafsson, U., Pramfalk, C., Binder, C.J., Petrillo, E., Garagnani, P. Paolo, Daub, C.O., Eriksson, M., Parini, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415860/ http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.428 |
Ejemplares similares
-
Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
por: Ahmed, Osman, et al.
Publicado: (2018) -
Insights From Liver‐Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR‐Agonist Pharmacodynamics in Humans
por: Minniti, Mirko E., et al.
Publicado: (2020) -
Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism
por: Gnocchi, Davide, et al.
Publicado: (2015) -
Epigenetic Variability across Human Populations: A Focus on DNA Methylation Profiles of the KRTCAP3, MAD1L1 and BRSK2 Genes
por: Giuliani, Cristina, et al.
Publicado: (2016) -
Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice
por: Pedrelli, Matteo, et al.
Publicado: (2014)